SMITH, M.

Clinical evaluation of moroctocog alfa (AF‐CC), a new generation of B‐domain deleted recombinant factor VIII (BDDrFVIII) for treatment of haemophilia A: demonstration of safety, efficacy, and pharmacokinetic equivalence to full‐length recombinant factor VIII

RECHT, M., NEMES, L., MATYSIAK, M., MANCO‐JOHNSON, M., LUSHER, J., SMITH, M., MANNUCCI, P., HAY, C., ABSHIRE, T., O’BRIEN, A., et al. (2009) · Haemophilia

Hemophilia Treatment and ResearchPlatelet Disorders and Treatments

Cited by 92

Acquired haemophilia A: errors in the diagnosis

Kazmi, M. A., Pickering, W., Smith, M. P., Holland, L. J., & Savidge, G. F. (1998) · Blood Coagulation & Fibrinolysis

Hemophilia Treatment and ResearchPlatelet Disorders and Treatments

Cited by 36